145 related articles for article (PubMed ID: 6140814)
1. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system.
Klusha B; Georgiev V; Petkov V; Markovska V
Acta Physiol Pharmacol Bulg; 1983; 9(2):14-9. PubMed ID: 6140814
[TBL] [Abstract][Full Text] [Related]
2. [Effect of some fragments of peptide hormones on the content of biogenic monoamines from mouse brain].
Zile RK; Odynets TG; Klusha VE
Biokhimiia; 1979 Jan; 44(1):93-96. PubMed ID: 33728
[TBL] [Abstract][Full Text] [Related]
3. Central action of melanostatin (MIF-1) in mice.
Brus R; Szkilnik R; Stanosek B; Makowska B; Piguła J
Acta Physiol Pol; 1984; 35(5-6):447-53. PubMed ID: 6152791
[TBL] [Abstract][Full Text] [Related]
4. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
Plotnikoff NP
Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
[No Abstract] [Full Text] [Related]
5. Central effects of angiotensin II, its fragment and analogues.
Georgiev VP; Klousha VE; Petkov VD; Markovska VL; Svirskis SV; Mountsinietse RK; Anouans ZE
Acta Physiol Pharmacol Bulg; 1984; 10(4):36-43. PubMed ID: 6085530
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacoethological analysis of the effects of thyroliberin and melanostatin in a model of anxious-defensive behavior in mice].
Poshivalov VP; Iurkevich AV; Tsakhaev GA
Biull Eksp Biol Med; 1987 Jun; 103(6):681-3. PubMed ID: 2885047
[TBL] [Abstract][Full Text] [Related]
7. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
[TBL] [Abstract][Full Text] [Related]
8. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
Voith K
Arzneimittelforschung; 1977; 27(12):2290-3. PubMed ID: 23795
[TBL] [Abstract][Full Text] [Related]
9. Central neurotropic activity of homovanillic acid.
Kleinrok Z; Zarkowski AM
Acta Physiol Pol; 1981; 32(5):477-85. PubMed ID: 7336983
[TBL] [Abstract][Full Text] [Related]
10. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
[TBL] [Abstract][Full Text] [Related]
11. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats.
Jedrusiak J; Brus R; Kostrzewa RM; Słowiński Z
Pol J Pharmacol; 1995; 47(1):43-52. PubMed ID: 7550548
[TBL] [Abstract][Full Text] [Related]
13. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
Pugsley TA; Lippmann W
Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
[TBL] [Abstract][Full Text] [Related]
14. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
[TBL] [Abstract][Full Text] [Related]
15. Neurotropic and pituitary effects of melanostatin (MIF), thyroliberin (TRH) and structurally related peptides.
Björkman S
Acta Pharm Suec; 1980; 17(6):352. PubMed ID: 6111892
[No Abstract] [Full Text] [Related]
16. Effects of postweaning undernutrition on exploratory behavior, memory and sensory reactivity in rats: implication of the dopaminergic system.
Alamy M; Errami M; Taghzouti K; Saddiki-Traki F; Bengelloun WA
Physiol Behav; 2005 Sep; 86(1-2):195-202. PubMed ID: 16099000
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the neuro- and immunomodulator properties of low-molecular neuropeptides].
Kukaĭn EM; Mutsenietse RK; Klusha VE
Biull Eksp Biol Med; 1982 Aug; 94(8):79-82. PubMed ID: 6127128
[TBL] [Abstract][Full Text] [Related]
18. [Psychopharmacologic spectrum of melanostatin].
Val'dman AV; Kozlovskaia MM; Klusha VE; Svirskis ShV
Biull Eksp Biol Med; 1980 Jun; 89(6):693-6. PubMed ID: 6104996
[TBL] [Abstract][Full Text] [Related]
19. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
[TBL] [Abstract][Full Text] [Related]
20. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
